2025

Cardiovascular phenotype in women 1-3 years after hypertensive pregnancy disorders: Impact of sex-independent and pregnancy-specific risk factors.
Klepp, Kristina, Moe, Kjartan, Angel, Kristin, von Lueder, Thomas G., Sugulle, Meryam, Ziesler, Charlotte P.Ø., Dechend, Ralf and Cathrine Staff, Anne
Pregnancy Hypertension 43 : 101404. March 2025 (In Press)

2024

Hypertensive disorders of pregnancy and long-term maternal cardiovascular risk: bridging epidemiological knowledge into personalized postpartum care and follow-up.
Staff, A.C., Costa, M.L., Dechend, R., Jacobsen, D.P. and Sugulle, M.
Pregnancy Hypertension 36 : 101127. June 2024

2020

Functional and structural vascular biomarkers in women 1 year after a hypertensive disorder of pregnancy.
Moe, K., Sugulle, M., Dechend, R., Angel, K. and Staff, A.C.
Pregnancy Hypertension 21 : 23-29. July 2020

2019

Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy.
Cunningham, M.W., Vaka, V.R., McMaster, K., Ibrahim, T., Cornelius, D.C., Amaral, L., Campbell, N., Wallukat, G., McDuffy, S., Usry, N., Dechend, R. and LaMarca, B.
Pregnancy Hypertension 15 : 72-77. January 2019

2017

Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - a role in placental and vascular health?
Moe, K., Heidecke, H., Dechend, R. and Staff, A.C.
Pregnancy Hypertension 10 : 83-89. October 2017

2012

Cardiovascular risk markers in pregnancies complicated by diabetes mellitus or preeclampsia.
Sugulle, M., Herse, F., Seiler, M., Dechend, R. and Staff, A.C.
Pregnancy Hypertension 2 (4): 403-410. October 2012